Terna Tablet (Terbinafine Hydrochloride)

Adult dose

As terbinafine: administer 125 mg once, twice a day, or 250 mg once a day. The administration period varies depending on the disease as follows: 1) Dermatophyte infections Athlete's foot (interdigital type, plantar type/moccasin type): 2–6 weeks Body ringworm: 2–4 weeks Jock itch: 2–4 weeks 2) Onychomycosis Usually treated for 6 weeks to 3 months. If infected nails or relatively small toes are involved, or if the patient is younger, the treatment period may be shortened to under 3 months. For toenail infections, a treatment period of about 3 months is generally sufficient, but in some patients, it may take 6 months or more. If the patient has a slow nail growth rate, the treatment period may be extended. 2. Children: Administer to children aged 2 years and older. There is no experience with those under 2 years, and it is not recommended for them. Tinea Capitis: 4 weeks Tinea capitis primarily occurs in children. To prevent recurrence of the infection, treatment must be followed properly for a regularly established duration. 1) Children under 20 kg (under 5 years old): Administer 62.5 mg once daily. Due to insufficient dosing experience, consider the benefits and risks of treatment before deciding on administration. 2) Children weighing 20–40 kg (ages 5–12): Administer 125 mg once daily. 3) Children exceeding 40 kg (over 12 years old): Administer 250 mg once daily. 3. Patients with renal impairment For patients with a creatinine clearance of less than 50 mL per minute, reduce the daily dose by 1/2.

Child dose

Administer to children aged 2 years and older. Do not recommend for children under 2 years. Tinea Capitis: 4 weeks 1) Children under 20 kg (under 5 years old): 62.5 mg once daily. Dosing experience

This medication is not recommended for patients with liver problems. Liver function tests must be conducted before administration, and liver function should be regularly monitored during treatment. If any abnormal liver functions occur, the use of the medication should be stopped immediately. Symptoms such as nausea, loss of appetite, fatigue, vomiting, abdominal pain, and jaundice should be reported to a physician immediately during treatment. This medication should not be used in patients with certain blood disorders, severely impaired kidney function, and nursing women. Moreover, it is not recommended for children under 2 years of age as safety has not been established. Care should be taken when administering it to elderly patients or small children, and if severe rashes or allergic reactions occur on the skin, the medication should be discontinued immediately. Special care is required for patients with psoriasis or systemic lupus erythematosus when using this medication. In addition to liver function, regular blood tests are necessary while taking this medication, as there may occasionally be serious skin reactions, muscle pain, or decreased blood pressure. Such symptoms should be discussed with medical personnel immediately. Be cautious, as dizziness may occur while driving or operating machinery. There may be interactions if taken with other medications, so it is essential to inform your doctor or pharmacist if you are currently taking any other medications. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before using this medication, and nursing women should stop breastfeeding during treatment. Overdosing may cause symptoms such as headache, nausea, abdominal pain, dizziness; in such cases, appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of reach of children and stored at room temperature away from direct sunlight.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, markedly reduced urine output

Mild side effects

Rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, leukopenia, anemia, photosensitivity reactions, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, bullous dermatitis, psoriasis-like rash, worsening of psoriasis, hair loss, arthralgia, myalgia, weakness, hypotension, dizziness, depression, anxiety, loss of taste, drowsiness, sensory abnormalities, decreased sensitivity, decreased attention, insomnia, increased BUN,

This medication may be sensitive to air and moisture. It should be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness and safety for a long time.

Appearance

White to nearly off-white round tablets

Package unit

30 tablets/bottle, 150 tablets/bottle